Search Results for "vitamin D"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vitamin D. Results 81 to 90 of 118 total matches.

Pemetrexed (Alimta) for Mesothelioma

   
The Medical Letter on Drugs and Therapeutics • Apr 12, 2004  (Issue 1180)
with vitamin B12 (1000 µg IM q9 weeks) and folic acid (350-1000 µg PO daily), started one week before ...
The combination of pemetrexed (Alimta - Lilly) and cisplatin is the first chemotherapy regimen approved by the FDA for treatment of malignant pleural mesothelioma. This uncommon malignancy, which has been linked to asbestos exposure, was previously considered unresponsive to chemotherapy, with a median survival of 6-8 months from diagnosis (VW Rusch, J Clin Oncol 2003; 21:2629).
Med Lett Drugs Ther. 2004 Apr 12;46(1180):31-2 |  Show IntroductionHide Introduction

Colon Cleansing

   
The Medical Letter on Drugs and Therapeutics • May 18, 2009  (Issue 1312)
oxide, and may also include vitamins, minerals, amino acids, herbs and probiotics. The laxative ...
Web sites and blogs are advising patients that periodic "cleansing" of the colon is necessary to rid the body of toxins.
Med Lett Drugs Ther. 2009 May 18;51(1312):39-40 |  Show IntroductionHide Introduction

Acetylcysteine (Acetadote) for Acetaminophen Overdosage

   
The Medical Letter on Drugs and Therapeutics • Aug 15, 2005  (Issue 1215)
or omission. EDITOR: Mark Abramowicz, M.D. DEPUTY EDITOR: Gianna Zuccotti, M.D., M.P.H., Weill Medical ...
Acetaminophen (paracetamol; Tylenol, and others) taken in overdosage can cause severe hepatic injury and death. Acetaminophen poisoning is treated with (N-)acetylcysteine. Available for many years in the US as a solution for inhalation therapy (Mucomyst, and others), it subsequently became available for oral use and was recently marketed in the US for intravenous (IV) use as Acetadote (Cumberland).
Med Lett Drugs Ther. 2005 Aug 15;47(1215):70-1 |  Show IntroductionHide Introduction

Home Testing of Cholesterol

   
The Medical Letter on Drugs and Therapeutics • Sep 30, 1994  (Issue 932)
of the colored column 10 to 12 minutes after the tab is pulled (D Noble, Anal Chem, 65:1037, 1993). The test ...
The new Advanced Care Cholesterol Test (Johnson & Johnson) now being advertised to the general public encourages patients to test their own serum cholesterol concentrations. Approved by the US Food and Drug Administration, this product is available in pharmacies without a prescription at a cost of about $20 for a single determination.
Med Lett Drugs Ther. 1994 Sep 30;36(932):85-6 |  Show IntroductionHide Introduction

Azelaic Acid - A New Topical Drug for Acne

   
The Medical Letter on Drugs and Therapeutics • Jun 07, 1996  (Issue 976)
for treatment of mild to moderate acne, used alone or in combination, are the vitamin A derivative tretinoin ...
Azelaic acid, a naturally occurring heptanedicarboxylic acid, has been marketed in the USA as a 20% cream (Azelex - Allergan) for treatment of acne. The drug has been available in Europe for several years.
Med Lett Drugs Ther. 1996 Jun 7;38(976):52-3 |  Show IntroductionHide Introduction

Fish Oil Supplements

   
The Medical Letter on Drugs and Therapeutics • Oct 15, 2012  (Issue 1401)
hypertriglyceridemia (>500 mg/dL). Lovaza (formerly Omacor) is available by prescription. The second FDA-approved ...
The FDA has approved 2 products containing omega-3 polyunsaturated fatty acids (PUFAs) for treatment of patients with severe hypertriglyceridemia (>500 mg/dL). Lovaza (formerly Omacor) is available by prescription. The second FDA-approved omega-3 product, Vascepa, which contains only EPA, will not be available until 2013. Many other brands of fish oil capsules are sold over the counter (OTC) as dietary supplements; the US Pharmacopeia has verified that some of these contain their labeled content, are soluble in the body, and contain neither heavy metals...
Med Lett Drugs Ther. 2012 Oct 15;54(1401):83-4 |  Show IntroductionHide Introduction

Chromium Supplementation

   
The Medical Letter on Drugs and Therapeutics • Jan 16, 2006  (Issue 1226)
or omission. EDITOR: Mark Abramowicz, M.D. DEPUTY EDITOR: Gianna Zuccotti, M.D., M.P.H., Weill Medical ...
Chromium is marketed as a dietary supplement, usually containing 20-500 mcg of a chromium salt. It has been promoted for weight loss, muscle building, and for prevention and treatment of diabetes, among other claims. As a dietary supplement, chromium can be sold without proof of efficacy or safety.
Med Lett Drugs Ther. 2006 Jan 16;48(1226):7-8 |  Show IntroductionHide Introduction

Resveratrol

   
The Medical Letter on Drugs and Therapeutics • Sep 21, 2009  (Issue 1321)
, sometimes combined with vitamins and other supplements. It is also an ingredient in some topical skin ...
Resveratrol is a phytochemical found in the skin of red grapes and in many other plants, including berries, plums and peanuts. As a constituent of red wine, it has been associated with cardioprotective effects. Dietary supplements containing resveratrol are now being widely promoted as antioxidants that can prevent agerelated diseases.
Med Lett Drugs Ther. 2009 Sep 21;51(1321):74-5 |  Show IntroductionHide Introduction

Pralatrexate (Folotyn) for Peripheral T-Cell Lymphoma

   
The Medical Letter on Drugs and Therapeutics • Jul 12, 2010  (Issue 1342)
of rest (7-week cycles). Patients must receive vitamin B 12 supplements intramuscularly every 8-10 ...
The FDA has approved pralatrexate (Folotyn – Allos), an intravenous (IV) antifolate, for treatment of adults with relapsed or refractory peripheral T-cell lymphoma (PTCL). It is the first drug approved by the FDA specifically for this indication.
Med Lett Drugs Ther. 2010 Jul 12;52(1342):55-6 |  Show IntroductionHide Introduction

In Brief: Orlistat OTC for Weight Loss

   
The Medical Letter on Drugs and Therapeutics • Jun 18, 2007  (Issue 1263)
. The drug also interferes with absorption of fat-soluble vitamins (A, D, E, K); the manufacturer recommends ...
The FDA has approved over-the-counter (OTC) sale of the weight-loss drug orlistat (Xenical – Roche)1 as alli (GlaxoSmithKline), to be used in combination with a reduced-calorie, low-fat diet. Orlistat binds to gastric and pancreatic lipases, preventing absorption of about 30% of dietary fat with the 120-mg prescription dose, and 25% with the 60-mg OTC dose. A 16-week controlled trial of the OTC dose (60 mg 3 times daily with meals) in overweight, not obese, patients (average BMI 26.8) on a reduced-calorie, low-fat diet found that patients taking the drug lost 1.15 kg more than those taking...
Med Lett Drugs Ther. 2007 Jun 18;49(1263):49 |  Show IntroductionHide Introduction